New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.
about
The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells.Emerging therapies in gastrointestinal cancers.Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapyLuteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomesCross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma.Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersShrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonistFrom somatostatin to octreotide LAR: evolution of a somatostatin analogueAnti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cellsThe immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer.Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesThe use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers.Evaluation of (99m)Tc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice.MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.Neuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
Q33552691-64383DD7-B7D7-4620-A4CD-6AF766E79BA0Q33866870-A0A5430B-42F7-4B6A-94D3-D774932526A3Q33927273-0C263B15-F31F-48FF-B356-34EA9FD57E44Q34110096-F2DB6F0B-F3A1-4B90-A52A-11EBA5B9E156Q34170191-0BD684AB-CC52-445C-BADF-B49C47F33741Q35964491-6E1DDC06-7D1B-4B62-A742-6DE70099EA90Q36116233-B5CCCD8F-258F-48A9-B2BC-6143D1197A6BQ36617058-419C15D6-10A7-466F-8B31-7367C0872847Q36919554-438F44D9-66E4-436B-BFD7-34A665480583Q36948906-5C50E02B-B56F-476F-B7DA-0E48A9EA1452Q37254566-97481B91-9334-432E-B0CF-020B96986E80Q37261898-D3E9924C-C8FF-43AD-99D1-F770AE9A0C4DQ37589369-3C4D2F3A-7ACD-4592-939B-C051EADA2ADEQ38216009-A892DE52-5A38-4EDF-85EA-F544395469D7Q38472348-9A7DCEAB-197F-445C-B568-12D088D1F3F1Q38829691-90F75A9A-1A0D-444B-B067-AB753A9E9579Q39105368-B8030409-32CE-4845-97AC-6948A898B7D7Q39428786-8AECCE1C-A8C7-4ABC-AA9A-93D9F4ED6EB0Q42117021-044BCE59-FA1F-4207-B85A-58EE16CAEE03Q43925665-BA3DE100-8B35-4C60-A0F1-EDF11A8A4EEEQ47652837-CB097A0F-324D-4E47-998D-E604DB5D7FB2Q50350314-7336F23E-2478-4053-A15C-4BD98AD2B9ADQ55709770-3CC06D2B-3B67-4591-9804-0F51B078AB33
P2860
New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New approaches to therapy of c ...... reas based on peptide analogs.
@ast
New approaches to therapy of c ...... reas based on peptide analogs.
@en
type
label
New approaches to therapy of c ...... reas based on peptide analogs.
@ast
New approaches to therapy of c ...... reas based on peptide analogs.
@en
prefLabel
New approaches to therapy of c ...... reas based on peptide analogs.
@ast
New approaches to therapy of c ...... reas based on peptide analogs.
@en
P2093
P1476
New approaches to therapy of c ...... creas based on peptide analogs
@en
P2093
A M Comaru-Schally
K Szepeshazi
P2888
P304
P356
10.1007/S00018-004-3434-3
P577
2004-05-01T00:00:00Z